The present invention relates to the method of stimulating the expression of endothelial NO-synthase in a mammal, which method comprises administering a physiologically active amount of 4-fluoro-N-indan-2-yl benzamide according to the formula (I) ##STR1## to the said mammal. The compound (I) can be used for the therapy and prophylaxis of cardiovascular diseases like stable and unstable angina pectoris, Prinzmetal angina (spasm), acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis, peripheral artery occlusive disease PAOD, atherosclerosis, restenosis, endothelial damage after PTCA, essential hypertension, pulmonary hypertension, secondary hypertension, renovascular chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, and the lowering of cardiovascular risk of postmenopausal women or after intake of contraceptives, the therapy and prophylaxis of diabetes and diabetes complications (nephropathy, retinopathy), angiogenesis, asthma bronchiale, chronic renal failure, cirrhosis of the liver, restricted memory performance or a restricted ability to learn.

A invenção atual relaciona-se ao método de estimular a expressão do Nenhum-synthase endothelial dentro um mamífero, que o método compreenda a administração de uma quantidade physiologically ativa do benzamide 4-fluoro-N-indan-2-yl de acordo com o ## do ## STR1 da fórmula (I) ao mamífero dito. O (I) composto pode ser usado para a terapia e a profilaxia de doenças cardiovascular como a angina pectoris estável e instável, o angina de Prinzmetal (spasm), o syndrome coronary agudo, falha de coração, infarction myocardial, curso, thrombosis, doença occlusive PAOD do artery periférico, atherosclerosis, restenosis, os danos endothelial após PTCA, o hypertension essencial, o hypertension pulmonary, o hypertension secundário, o glomerulonephritis crônico renovascular, o dysfunction erectile, o arrhythmia ventricular, e abaixar do risco cardiovascular de mulheres postmenopausal ou após a entrada dos contraceptivos, da terapia e da profilaxia do diabetes e de complicações do diabetes (nephropathy, retinopathy), angiogenesis, bronchiale do asthma, falha renal crônica, cirrhosis do fígado, restringiu desempenho da memória ou uma abilidade restrita aprender.

 
Web www.patentalert.com

< (none)

< Medical treatment

> Selective .beta.3 adrenergic agonists

> (none)

~ 00083